BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3041354)

  • 1. Respiratory syncytial virus infections and intravenous gamma-globulins.
    Hemming VG; Prince GA; Rodriguez W; Kim HW; Brandt CD; Parrott RH; London WT; Fischer GW; Baron PA; Henson SA
    Pediatr Infect Dis J; 1988 May; 7(5 Suppl):S103-6. PubMed ID: 3041354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylaxis in RSV infection (Palivizumab)--is it worthwhile?
    Hashmi NA; Cosgrove JF; MacMahon P
    Ir Med J; 2000 Dec; 93(9):284. PubMed ID: 11209917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoprophylaxis of infections with respiratory syncytial virus: observations and hypothesis.
    Hemming VG; Prince GA
    Rev Infect Dis; 1990; 12 Suppl 4():S470-4; discussion S474-5. PubMed ID: 2194271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Respiratory syncytial virus and parainfluenza virus infections in the immunocompromised host.
    Wendt CH; Hertz MI
    Semin Respir Infect; 1995 Dec; 10(4):224-31. PubMed ID: 8668850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ribavirin aerosol treatment of serious respiratory syncytial virus infection in infants.
    Rodriguez WJ; Parrott RH
    Infect Dis Clin North Am; 1987 Jun; 1(2):425-39. PubMed ID: 3332796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoglobulin administration and ribavirin therapy: efficacy in respiratory syncytial virus infection of the cotton rat.
    Gruber WC; Wilson SZ; Throop BJ; Wyde PR
    Pediatr Res; 1987 Mar; 21(3):270-4. PubMed ID: 3550674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections.
    American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn
    Pediatrics; 2003 Dec; 112(6 Pt 1):1442-6. PubMed ID: 14654627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Respiratory syncytial virus immune globulin treatment of lower respiratory tract infection in pediatric patients undergoing bone marrow transplantation - a compassionate use experience.
    DeVincenzo JP; Hirsch RL; Fuentes RJ; Top FH
    Bone Marrow Transplant; 2000 Jan; 25(2):161-5. PubMed ID: 10673674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management and prevention strategies for respiratory syncytial virus (RSV) bronchiolitis in infants and young children: a review of evidence-based practice interventions.
    Cooper AC; Banasiak NC; Allen PJ
    Pediatr Nurs; 2003; 29(6):452-6. PubMed ID: 14743842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination therapy with aerosolized ribavirin and intravenous immunoglobulin for respiratory syncytial virus disease in adult bone marrow transplant recipients.
    Whimbey E; Champlin RE; Englund JA; Mirza NQ; Piedra PA; Goodrich JM; Przepiorka D; Luna MA; Morice RC; Neumann JL
    Bone Marrow Transplant; 1995 Sep; 16(3):393-9. PubMed ID: 8535312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous immunoglobulin treatment of respiratory syncytial virus infections in infants and young children.
    Hemming VG; Rodriguez W; Kim HW; Brandt CD; Parrott RH; Burch B; Prince GA; Baron PA; Fink RJ; Reaman G
    Antimicrob Agents Chemother; 1987 Dec; 31(12):1882-6. PubMed ID: 3439796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous palivizumab and ribavirin combination for respiratory syncytial virus disease in high-risk pediatric patients.
    Chávez-Bueno S; Mejías A; Merryman RA; Ahmad N; Jafri HS; Ramilo O
    Pediatr Infect Dis J; 2007 Dec; 26(12):1089-93. PubMed ID: 18043443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Respiratory syncytial virus infection in patients with hematological diseases: single-center study and review of the literature.
    Khanna N; Widmer AF; Decker M; Steffen I; Halter J; Heim D; Weisser M; Gratwohl A; Fluckiger U; Hirsch HH
    Clin Infect Dis; 2008 Feb; 46(3):402-12. PubMed ID: 18181739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary infections with respiratory syncytial virus and the parainfluenza viruses.
    Henderson FW
    Semin Respir Infect; 1987 Jun; 2(2):112-21. PubMed ID: 2827280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Respiratory tract infections caused by respiratory syncytial virus in children. Diagnosis and treatment.
    Van Woensel JB; Kimpen JL; Brand PL
    Minerva Pediatr; 2001 Apr; 53(2):99-106. PubMed ID: 11404731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of the infant with respiratory syncytial virus.
    Corey MA; Clore ER
    J Pediatr Nurs; 1991 Apr; 6(2):93-8. PubMed ID: 2019971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Respiratory syncytial virus infection in infants and young children.
    Levy BT; Graber MA
    J Fam Pract; 1997 Dec; 45(6):473-81. PubMed ID: 9420581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Respiratory syncytial virus infection in childhood].
    Hammer J
    Schweiz Med Wochenschr; 1998 Sep; 128(37):1366-74. PubMed ID: 9783360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group.
    Pediatrics; 1998 Sep; 102(3 Pt 1):531-7. PubMed ID: 9738173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Respiratory syncytial virus infection in adults.
    Falsey AR
    Semin Respir Crit Care Med; 2007 Apr; 28(2):171-81. PubMed ID: 17458771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.